Tomoyuki Fujisawa

46PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersMedical microbiology not elsewhere classifiedMedical mycologyRespiratory diseasesCell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Feb 18, 2026
Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD).

Kazuya Tsubouchi, Masayuki Hirose, Reoto Takei

|Feb 13, 2026
Amiodarone-Induced Pneumonia Without Foamy Macrophages in the BALF: A Diagnostic Challenge Unveiled by Cryobiopsy.

Tomo Tsunoda, Kazuo Tsuchiya, Yoshiyuki Oyama

|Jan 23, 2026
Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

Yoshihiro Kitahara, Tomoyuki Fujisawa, Atsuki Fukada

|Oct 15, 2025
Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study.

Masato Karayama, Koichi Miyashita, Yusuke Inoue

|Aug 14, 2025
PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease.

Kyohei Oishi, Hideki Yasui, Yusuke Inoue

|Jun 10, 2025
Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis.

Yuzo Suzuki, Masato Kono, Hirotsugu Hasegawa

Pageof 8

Frequent Collaborators

31 joint publications

Hironao Hozumi

26 joint publications

Yuzo Suzuki

22 joint publications

Noriyuki Enomoto

16 joint publications

Hideki Yasui